◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › N › NYXH

Nyxoah SA (NYXH) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-09-03

Nyxoah SA (NYXH) operates in the Medical Devices industry and is headquartered in Mont-Saint-Guibert, Belgium with about 153 employees. Its market capitalization is roughly $154 million. In the fiscal year ended 2025-12-31, NYXH reported €10M in revenue and (€90M) in net income.

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.

Interactive charts & full statements → Open the NYXH valuation workbench →

NYXH Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	€10M	€4M	€4M	€3M
Gross Profit	€6M	€3M	€3M	€2M
Operating Income (EBIT)	(€83M)	(€59M)	(€45M)	(€32M)
Net Income	(€90M)	(€59M)	(€43M)	(€31M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NYXH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	€8M	€6M	€6M	€2M	€1M
Gross Profit	€5M	€4M	€4M	€1M	€1M
Operating Income (EBIT)	(€20M)	(€20M)	(€18M)	(€24M)	(€20M)
Net Income	(€33M)	(€16M)	(€24M)	(€24M)	(€21M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NYXH Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	€0M	€0M	€0M	€0M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NYXH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	€0M	€0M	€0M	€0M	€0M	—	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NYXH Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€118M	€158M	€124M	€146M	—
Total Liabilities	€69M	€45M	€26M	€26M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NYXH viewer.

Other Companies in Medical Devices

2297 · Rainmed Medical Limited — HK$231 million
STIM · Neuronetics, Inc. — $219 million
LUCD · Lucid Diagnostics Inc. — $189 million
QSI · Quantum-Si incorporated — $167 million
EPIT · Epitomee Medical Ltd — ₪148 million
OWLT · Owlet, Inc. — $148 million
INGN · Inogen, Inc. — $143 million
MXCT · MaxCyte, Inc. — $131 million

← NYT All “N” companies NYYY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.